Literature DB >> 11488674

Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age.

K Breuer1, A Kapp, T Werfel.   

Abstract

BACKGROUND: Eosinophils are important effector cells in several atopic diseases. The levels of eosinophil granule-derived mediators (ECP, EPX) in serum and body fluids have been proven to be correlated with disease activity in atopic respiratory diseases and atopic dermatitis. The study aimed to demonstrate an interrelationship between urine EPX and disease activity in adult patients with atopic dermatitis.
METHODS: We determined urine EPX concentration, serum ECP concentration, and peripheral blood eosinophil count in 40 adult patients with mild to severe atopic dermatitis and compared it with the disease activity as assessed with the SCORAD index.
RESULTS: Urine EPX and serum ECP concentrations were significantly higher in patients with severe atopic dermatitis than in patients with mild or moderate disease (median values 123.5 vs 78.3 microg/mmol creatinine, P<0.0001; 25.4 vs 14.9 microg/l, P<0.0001, respectively). We found a significant correlation between urine EPX levels, serum ECP levels, and the SCORAD (r=0.36, P<0.0001 and 0.34, P<0.0001, respectively).
CONCLUSION: Urine EPX is a useful in vitro parameter of inflammation in atopic dermatitis of the adult age.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488674     DOI: 10.1034/j.1398-9995.2001.056008780.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  5 in total

1.  An extragranular compartment of blood eosinophils contains eosinophil protein X/eosinophil-derived neurotoxin (EPX/EDN).

Authors:  Malgorzata Karawajczyk; Christer G B Peterson; Per Venge; Rodolfo C Garcia
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

Review 2.  IgE, mast cells, and eosinophils in atopic dermatitis.

Authors:  Fu-Tong Liu; Heidi Goodarzi; Huan-Yuan Chen
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

3.  Clinical and Biological Markers in Hypereosinophilic Syndromes.

Authors:  Paneez Khoury; Michelle Makiya; Amy D Klion
Journal:  Front Med (Lausanne)       Date:  2017-12-22

Review 4.  Cellular aspects of atopic dermatitis.

Authors:  Liang-Shiou Ou; Jing-Long Huang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 10.817

5.  Variation in genes encoding eosinophil granule proteins in atopic dermatitis patients from Germany.

Authors:  Qumar Parwez; Susanne Stemmler; Jörg T Epplen; Sabine Hoffjan
Journal:  J Negat Results Biomed       Date:  2008-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.